Trial of Microbiota Transplant in Treating Patients Opens in Australia

Trial of Microbiota Transplant in Treating Patients Opens in Australia

301842

Trial of Microbiota Transplant in Treating Patients Opens in Australia

BiomeBank is launching a trial in Australia to test whether its fecal microbiota transplantation therapy, which works to replenish gut bacteria, is a safe, tolerable and effective treatment of Parkinson’s disease symptoms, such as constipation. The trial is being conducted in collaboration with the Royal Adelaide and Queen Elizabeth hospitals and The Hospital Research Foundation (THRF) Group, and is currently recruiting participants for the study. People with a confirmed diagnosis of idiopathic Parkinson’s (disease without a known…

You must be logged in to read/download the full post.